IL-10-producing and naturally occurring CD4+ Tregs:: limiting collateral damage

被引:412
作者
O'Garra, A
Vieira, PL
Vieira, P
Goldfeld, AE
机构
[1] Natl Inst Med Res, Div Immunoregulat, London NW7 1AA, England
[2] CNRS, URA 1961, Unite Dev Lymphocytes, Paris, France
[3] Harvard Univ, Sch Med, Biomed Res Inst, CBR, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA
关键词
D O I
10.1172/JCI200423215
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Effective immune responses against pathogens are sometimes accompanied by strong inflammatory reactions. To minimize damage to self, the activation of the immune system also triggers anti-inflammatory circuits. Both inflammatory and anti-inflammatory reactions are normal components of the same immune response, which coordinately fight infections while preventing immune pathology. IL-10 is an important suppressive cytokine, produced by a large number of immune cells in addition to the antigen-driven IL-10-producing regulatory and the naturally occurring suppressor CD4(+) T cells, which is a key player in anti-inflammatory immune responses. However, additional mechanisms have evolved to ensure that pathogen eradication is achieved with minimum damage to the host. Here we discuss those mechanisms that operate to regulate effector immune responses.
引用
收藏
页码:1372 / 1378
页数:7
相关论文
共 105 条
  • [1] Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens
    Aandahl, EM
    Michaëlsson, J
    Moretto, WJ
    Hecht, FA
    Nixon, DF
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (05) : 2454 - 2459
  • [2] Functional diversity of helper T lymphocytes
    Abbas, AK
    Murphy, KM
    Sher, A
    [J]. NATURE, 1996, 383 (6603) : 787 - 793
  • [3] Akbari O, 2002, NAT MED, V8, P1024, DOI 10.1038/nm745
  • [4] Role of IL-10 in allergen-specific immunotherapy and normal response to allergens
    Akdis, CA
    Blaser, K
    [J]. MICROBES AND INFECTION, 2001, 3 (11) : 891 - 898
  • [5] CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10
    Annacker, O
    Pimenta-Araujo, R
    Burlen-Defranoux, O
    Barbosa, TC
    Cumano, A
    Bandeira, A
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (05) : 3008 - 3018
  • [6] An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation
    Asseman, C
    Mauze, S
    Leach, MW
    Coffman, RL
    Powrie, F
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (07) : 995 - 1003
  • [7] In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines
    Barrat, FJ
    Cua, DJ
    Boonstra, A
    Richards, DF
    Crain, C
    Savelkoul, HF
    de Waal-Malefyt, R
    Coffman, RL
    Hawrylowicz, CM
    O'Garra, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (05) : 603 - 616
  • [8] CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity
    Belkaid, Y
    Piccirillo, CA
    Mendez, S
    Shevach, EM
    Sacks, DL
    [J]. NATURE, 2002, 420 (6915) : 502 - 507
  • [9] The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure
    Belkaid, Y
    Hoffmann, KF
    Mendez, S
    Kamhawi, S
    Udey, MC
    Wynn, TA
    Sacks, DL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (10) : 1497 - 1506
  • [10] Interleukin-10, T regulatory cells and specific allergy treatment
    Blaser, K
    Akdis, CA
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2004, 34 (03) : 328 - 331